All In Biotech

Free tool

FAERS Monitor: Lialda

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022000 or its brand name (Lialda, Mesalamine). Reports on generic versions are filed under their own applications.

Reports

36,767

Serious

29,039

79% of reports

Hospitalization

11,298

Death reported

2,144

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use6,841
  • drug ineffective5,388
  • colitis ulcerative5,375
  • condition aggravated3,686
  • diarrhoea3,406
  • haematochezia2,959
  • fatigue2,745
  • abdominal pain2,577
  • headache2,274
  • nausea2,274
  • pyrexia2,151
  • weight decreased2,149
  • frequent bowel movements2,006
  • pain1,985
  • arthralgia1,982

Reports by year received

View as table
YearReports
2004106
2005149
2006106
2007165
2008638
2009274
2010367
2011951
2012959
2013638
20141,219
20151,654
20161,455
20171,062
20181,202
20191,226
20201,578
20212,800
20224,468
20234,564
20244,371
20254,286
20262,528

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,017,392 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
colitis ulcerativeSignal5,37578.076.0360,407
frequent bowel movementsSignal2,00645.843.881,456
haematocheziaSignal2,95932.331.285,261
condition aggravatedSignal3,6867.06.819,025
abdominal painSignal2,5776.46.211,728
off label useSignal6,8414.54.419,253
weight decreasedSignal2,1494.44.35,736
pyrexiaSignal2,1513.63.44,023
diarrhoeaSignal3,4063.02.94,749
arthralgiaSignal1,9822.72.62,213
drug ineffectiveSignal5,3882.32.34,411
headacheSignal2,2742.12.01,306
fatigueSignal2,7452.01.91,463
pain1,9851.91.8797
nausea2,2741.61.6596

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.